Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 56990-02-4 | MDL No. : | MFCD00156887 |
Formula : | C7H4Br2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZLDMZIXUGCGKMB-UHFFFAOYSA-N |
M.W : | 263.91 | Pubchem ID : | 622077 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.23 |
TPSA : | 17.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.39 cm/s |
Log Po/w (iLOGP) : | 2.02 |
Log Po/w (XLOGP3) : | 3.55 |
Log Po/w (WLOGP) : | 3.02 |
Log Po/w (MLOGP) : | 2.94 |
Log Po/w (SILICOS-IT) : | 3.34 |
Consensus Log Po/w : | 2.97 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.09 |
Solubility : | 0.0214 mg/ml ; 0.0000811 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -3.59 |
Solubility : | 0.0673 mg/ml ; 0.000255 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.05 |
Solubility : | 0.0234 mg/ml ; 0.0000887 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.37 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | Stage #1: With magnesium In tetrahydrofuran at 20℃; for 0.0833333 h; Inert atmosphere; Large scale Stage #2: With methylmagnesium chloride In tetrahydrofuran for 3.5 h; Reflux; Inert atmosphere; Large scale Stage #3: at 0 - 10℃; for 2 h; Inert atmosphere; Large scale |
under the protection of nitrogen gas the 25kg of tetrahydrofuran, 400g of tribromobenzene and Fresh magnesium tablets 500g were added to reaction kettle and stirred for 5min at room temperature. cooled down the reaction to 0°C then catalytic amount 120g of Methylmagnesium chloride was added and raised the temperature to reflux. After the initiation , control temperature to 55-60 ° C for adding tribromobenzene 4kg in batches , after about 3 hours of addition the temperature was raised to reflux insulation for 30 minutes; cooled down the reaction to 0°C, then 1.5kf of DMF was added drop wise and addition was completed within 1hour. And then slowly raising temperature to 5-10 ° C and incubated for 1 hour. After the reaction, add 15percent hydrochloric acid for acidification , temperature controlled at 10 ° C for 1 hour. The solution is then allowed to stand for separation. Water phase was extracted with ethyl acetate , The organic phase was combined, concentrated, the17.5kg of petroleum ether was added, the temperature was raised to reflux and then cooled to 0 ° C, and the temperature was maintained for 1 hour. The product subjected to centrifugation and drying to give 3,5-dibromobenzaldehyde. Content of 99.5percent (GC), the yield of 95percent. |
70% | Stage #1: With n-butyllithium In diethyl ether at -78℃; for 0.75 h; Inert atmosphere; Schlenk technique Stage #2: for 1 h; Inert atmosphere; Schlenk technique |
Compound 2 was synthesized according to the literature [22].Briefly, a suspension of 1,3,5-tribromobenzene (4.0 g,12.7 mmol) inanhydrous diethyl ether (100 mL) at -78 C was treated dropwisewith butyllithium (2.5 M, 5.3 mL, 13.5 mmol). After 45 min, DMF(2.8 g, 38.3 mmol) was droped into the mixture, which was thenstirred for another 1 h. Diluted HCl (40 mL, 2 mol/L) was added,then organic phase was removed, and a brown solid was obtained.The crude product was purified by column chromatography (silicagel) using DCM/n-hexane = 1/10 as eluent and recrystallized fromdiethyl ether/n-hexane to give needle compound 2 (2.34 g, 70percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With 4-methylmorpholine N-oxide In tetrahydrofuran for 12 h; Reflux | A solution of compound C (3.29 g, 10 mmol) and 4-methyl-n-oxo morpholine (3.51 g, 30 mmol) were dissolved in 60 mL of tetrahydrofuran and the reaction mixture was heated under reflux for 12 hours. The organic compound was dried over magnesium sulfate and dried over silica gel column chromatography using dichloromethane / petroleum ether (v / v = 2: 3) as eluent. After drying and steaming, the mixture was dried to give the intermediate D (2.42 g, yield 92percent) as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With magnesium In hexane; dichloromethane; ethyl acetate; N,N-dimethyl-formamide | STR12 Preparation of 3,5-dibromobenzaldehyde 1.344G (56 mM) of magnesium was added to a solution of 15-7G(50 mM) of 1,3,5-tribromobenzene and the mixture was stirred at room temperature after 5 hours, most of the metal was digested. To the resulting brown Grignard solution was added 7.5 mL (0.1M) of N,N-dimethylformamide at 0° under nitrogen. The resulting mixture was stirred overnight at room temperature. Solvent was removed in vacuo at room temperature. The residue was taken up in 200 mL of ethyl acetate and washed with 6*50 mL of saturated sodium chloride solution, dried over anhydrous MgSO4. Solvent was removed to give a crude solid, which was dissolved in minimum amount of CH2 Cl2 and applied on silica gel. Elution with 1:9 mixture of ether:hexane containing methylene chloride gave 45percent yield of the desired aldehyde as white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With sodium tetrahydroborate In methanol at 0 - 20℃; for 1 h; | Example 15 [4-[3,5-Bis-[(4-trifluoromethylphenyl)ethynyl]benzyloxy]-2-methylphenoxy]acetic acid 3,5-Dibromobenzaldehyde (1.7 g, 6.3 mmol) was dissolved in methanol (100 mL) and sodium borohydride (0.250 g, 6.3 mmol) was added at 0° C. The reaction mixture was stirred for 0.5 h at 0° C. and then at 20° C. for another 0.5 h. The reaction mixture was concentrated in vacuo, diluted with brine (250 mL), acidified with hydrochloric acid and extracted with dichloromethane (3*50 mL). Evaporation of the organic solution gave 3,5-dibromo-benzyl alcohol as a white crystalline compound. Yield: 1.4 g (84percent). RF (SiO2, hexanes/ethyl acetate 9:1) 0.25. 1H NMR spectrum (300 MHz, CDCl3, A) 7.59 (d, J=1.5 Hz, 1H); 7.47 (d, J=1.5 Hz, 2H); 4.36 (s, 2H); 1.55 (s, 1H). |
84% | With sodium tetrahydroborate In methanol at 0 - 20℃; for 1 h; | Example 15; [4-[3,5-Bis-[(4-trifluoromethylphenyl)ethynyl]benzyloxy]-2-methylphenoxy]acetic acid; 3,5-Dibromobenzaldehyde (1.7 g, 6.3 mmol) was dissolved in methanol (100 mL) and sodium borohydride (0.250 g, 6.3 mmol) was added at 0 °C. The reaction mixture was stirred for 0.5 h at 0 °C and then at 20 °C for another 0.5 h. The reaction mixture was con- centrated in vacuo, diluted with brine (250 mL), acidified with hydrochloric acid and extracted with dichloromethane (3 x 50 mL). Evaporation of the organic solution gave 3,5-dibromo- benzyl alcohol as a white crystalline compound. Yield: 1.4 g (84 percent). RF (Si02, hexanes/ethyl acetate 9:1) 0.25. 1H NMR spectrum (300 MHz, CDCl3, No.H) : 7.59 (d, J=1.5 Hz, 1 H) ; 7.47 (d, J=1.5 Hz, 2 H); 4.36 (s, 2 H); 1.55 (s, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
56% | Stage #1: With sodium hydroxide In ethanol at 20℃; for 8 h; Stage #2: With sodium hydroxide In ethanol for 8 h; Reflux |
3,5-dibromobenzaldehyde (1 0.56g, 40 mmol) and acetophenone (4.81, 40 mmol) were dissolved in ethanol (80 mL), and sodium hydroxide (0.16g, 4 mmol) was added. The resulting solution was stirred at room temperature for 8 hours. Then, benzamidine hydrochloride (4.70g, 30 mmol), sodium hydroxide (1.60g, 40 mmol) and ethanol (40 mL) were added, and the resulting solution was reacted while heating under reflux for 8 hours. White powder generated was filtered off and washed with ethanol until the liquid became colorless. The powder was further washed with water and ethanol and then dried in vacuum to obtain intermediate N (5.20g, yield: 56percent). |